Digital Health Global

JANUARY 26, 2024

Under the program, Deliberate AI’s assessment tool for anxiety and depression, the AI-generated Clinical Outcome Assessment or AI-COA , will receive support to become a qualified drug development tool (DDT). Global experts have also expressed support for Deliberate AI’s innovative approach.

Drug Development 88

Drug Development Mental health Psychiatry Digital Health 88

Digital Health Global

NOVEMBER 2, 2023

Wearable monitoring devices, genomics, and AI play vital roles in this transformation, enabling personalized interventions and collective health data sharing for research. Drug development The traditional drug discovery process is characterized by its protracted timeline, high costs, and significant attrition rates among drug candidates.

Drug Development 88

Drug Development Pharmaceuticals Public Health Telehealth 88

Healthcare IT News - Telehealth

MAY 6, 2020

Editor’s Note: This feature story initially was published on May 6, 2020. The quickly evolving COVID-19 public health emergency has warranted the growing use of telehealth and non-invasive remote monitoring devices to facilitate patient monitoring while reducing patient and healthcare provider contact and possible exposure to the virus.

Connected Health 188

Connected Health Telehealth Pharmaceuticals EHR 188